Mizuho Initiates Coverage On AbbVie with Buy Rating, Announces $96 Price Target

Mizuho analyst Vamil Divan initiates coverage on AbbVie (NYSE:ABBV) with a Buy rating and a $96 price target.

Benzinga · 02/06/2020 10:10

Mizuho analyst Vamil Divan initiates coverage on AbbVie (NYSE:ABBV) with a Buy rating and a $96 price target.